Pacific Biosciences of California Inc PACB
News
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
PacBio Appoints Mark Van Oene as President and Chief Executive Officer
PacBio Announces Second Quarter 2026 Financial Results
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
